meclizine 25 mg
1 INDICATIONS AND USAGE Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults ( 1 ).
aurobindo pharma limited
ROUND WHITE C 25
Related Pills
meclizine 50 mg
aurobindo pharma limited
meclizine 12.5 mg
aurobindo pharma limited
Clintabs clindamycin 25 mg
virbac ah, inc.
Clozapine 25 MG Disintegrating Oral Tablet
Mylan Pharmaceuticals Inc.
Meloxicam meloxicam 7.5 MG Oral Tablet
International Labs, Inc.
meloxicam 7.5 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
meloxicam 7.5 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
meloxicam 7.5 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
Meloxicam meloxicam 7.5 MG Oral Tablet
International Laboratories, LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
MECLIZINE Hydrochloride Tablets, USP are available containing 12.5 mg, 25 mg or 50 mg of
MECLIZINE dihydrochloride equivalent to 10.53 mg, 21.07 mg or 42.14 mg of
MECLIZINE free base, respectively. The 12.5 mg tablets are a white to off-white 7.14 mm round, biconvex, beveled edge tablets debossed with 12 on one side of tablet and C on the other side of tablet. They are available as follows: Bottles of 100 NDC 59651-807-01 Bottles of 1,000 NDC 59651-807-99 The 25 mg tablets are a white to off-white 8.73 mm round, biconvex, beveled edge tablets debossed with 25 on one side of tablet and C on the other side of tablet. They are available as follows: Bottles of 100 NDC 59651-808-01 Bottles of 1,000 NDC 59651-808-99 The 50 mg tablets are a white to off-white 10.32 mm round, biconvex, beveled edge tablets debossed with C above the score on one side of tablet and 50 on the other side of tablet. They are available as follows: Bottles of 90 NDC 59651-809-90 Bottles of 500 NDC 59651-809-05 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
More pills like ROUND C 25